Login / Signup

Effectiveness of aprepitant in post-acute COVID19 syndrome.

Rocio Reinoso-ArijaCecilia Lopez RamirezJosé Antonio Jimenez-RuizJosé Luis López-Campos
Published in: Clinical case reports (2021)
This is the first case of a patient taking aprepitant for a post-acute COVID-19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.
Keyphrases
  • case report
  • coronavirus disease
  • sars cov
  • liver failure
  • respiratory failure
  • systematic review
  • drug induced
  • aortic dissection
  • respiratory syndrome coronavirus
  • mechanical ventilation